Dave Lashmet

Alzheimer's drug sales are gaining momentum as Leqembi and Kisunla expand globally and new P-Tau blood tests transform diagnosis. Here's what biotech investors need to know.

Novo Nordisk leads the race for the first Alzheimer’s prevention pill, with insights on clinical progress and what investors should know about this breakthrough.